Sunday, 26 August 2012
Dictionary
hide playlisthide playlist
Tulsa World Dear Doctor K: What can I do about edema? The diuretics my doctor prescribed haven't helped. Dear Reader: Edema is swelling caused by a buildup of extra fluid. Edema most often affects the feet and legs, but it can affect the hands and the face. The fluid in your body is in three places: inside each...(size: 3.2Kb)
New York Daily News Swiss pharma giant Roche said Monday it will sell in the United States a drug that treats a diabetes-related illness linked to blindness after getting the regulatory green light. The Food and Drug Administration's (FDA) decision...(size: 1.5Kb)
The Examiner Related topics FDAnew drughealthy livingeye diseasediabetes Advertisement Those suffering from diabetic macular edema have new hope for treating their eye disease. The U.S. Food and Drug Administration recently approved Lucentis for those suffering from this condition. Diabetic macular edema is a...(size: 6.7Kb)
The Examiner Related topics diabetesLucentismacular degeneration Advertisement The FDA has just approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease in which fluid leaks into the macula, the center part of the retina where sharp,...(size: 8.0Kb)
PhysOrg The drug is the first and only FDA-approved medicine for DME, a condition for which the standard of care has not changed significantly in more than 25 years. To date, the usual resort in the United States has been laser surgery, which slows the rate of vision loss and helps stabilize vision, but has...(size: 3.2Kb)
noodls Basel, 13 August 2012 FDA approves Lucentis (ranibizumab injection) for treatment of diabetic macular edema First major treatment advance in more than 25 years for sight-threatening condition Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Lucentis (ranibizumab injection) was approved by the...(size: 12.4Kb)
noodls FDA NEWS RELEASE For Immediate Release: Aug. 10, 2012 Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA approves Lucentis to treat diabetic macular edema The U.S. Food and Drug Administration today approved Lucentis (ranibizumab injection)...(size: 4.7Kb)
Business Wire -- First Major Treatment Advance in More Than 25 Years for Sight-Threatening Condition -- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that Lucentis® (ranibizumab injection) was approved by the U.S. Food & Drug...(size: 19.4Kb)
noodls 08/01/2012 | Press Release Greenwood Village, Colorado, August 1, 2012 - PRNewswire - Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a clinical stage biopharmaceutical company developing drugs for the treatment of inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual...(size: 9.0Kb)
PR Newswire My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about AMPE...(size: 9.7Kb)